Zinc is mostly subclinical. You don't feel zinc the way you feel modafinil or a creatine load. What you notice is what stops happening when you have enough:

• Frequent illness pattern resolves — the chronic "I get every cold that comes through the gym" pattern often softens within 4–8 weeks of repletion. Acute lozenge protocols (75 mg elemental in divided doses, started <24 h of first sniffle) commonly produce a noticeable shortened cold within that single illness.
• Taste and smell sharpen if you were marginal. Many people don't realize their gustatory baseline drifted until they replete and food becomes more vivid.
• Skin — acne improves modestly, wound healing (mat burns, splits, friction abrasions) noticeably faster. Some users describe a subtle "skin quality" improvement at 4–6 weeks.
• Sex drive / morning erections — usually unchanged in a young eugonadal man with adequate baseline zinc. If you went from deficient to replete you may notice modest libido restoration; it's not a libido-enhancer.
• Acute high-dose feel: 50+ mg fasted is reliably nauseating. The "zinc gut-punch" 30 minutes after a fasted picolinate is one of the most consistent subjective complaints in the community data. Take with food.

What you should NOT feel: stimulation, energy, mood lift. If you're getting those, it's placebo or an inactive ingredient. Zinc is foundational, not euphoric.

Zinc doesn't develop classical pharmacological tolerance — it's a mineral substrate, not a receptor agonist. However, two mechanisms create something tolerance-adjacent:

1. Adaptive downregulation of absorption: Chronic high zinc intake downregulates ZIP4 expression in enterocytes, reducing fractional absorption. The body homeostatically defends against zinc overload. Implication: pushing dose chronically yields diminishing returns above ~25 mg/day.
2. Progressive copper depletion: Without copper co-supplementation, the "tolerance" you see is actually the user feeling progressively worse as copper-dependent enzymes (ceruloplasmin, cytochrome c oxidase, lysyl oxidase) lose function. Looks like supplement failure; is actually iatrogenic copper deficiency.

Cycling strategy:

• No cycling needed for maintenance dose (15–25 mg/day with copper). This is a foundational mineral; intermittent dosing has no rationale.
• Acute lozenge protocols (75–90 mg/day for <7 days during URTI) require a return to maintenance, not a "rest" off zinc entirely.
• If you suspect over-supplementation: 4-week washout, recheck biomarkers, then reset at lower maintenance.
• Stack stacking risk: Multivitamins frequently contain 15 mg zinc; ZMA contains 30 mg; men's-health blends often add another 15 mg. Audit total zinc across all SKUs in your stack — over-stacking is the most common real-world toxicity pathway.

Synergistic / complementary

• Copper (1–2 mg bisglycinate or gluconate): mandatory pairing at any chronic zinc dose >25 mg/day. Maintains the ~15:1 zinc:copper ratio. Take together — they compete for absorption but if you're co-dosing both, your ratio stays right.
• Vitamin A: zinc is required for retinol-binding protein synthesis. Vitamin A status drives zinc-dependent visual and immune function. Co-deficient states are common globally.
• Vitamin D3 + K2: foundational stack pillar. Zinc + D3 commonly co-low in athletes. No direct interaction; complementary.
• Magnesium glycinate (separate timing): divalent cation competition for absorption is theoretical; in practice the doses biohackers use don't meaningfully interfere. The original ZMA formulation pairs them at bedtime — fine for convenience, but no synergistic hormonal effect beyond what each provides solo.
• Vitamin C / citric acid (food sources): enhance non-heme zinc absorption when consumed with food zinc; less relevant for chelated supplements.
• Quercetin (zinc ionophore): boosts intracellular zinc transport into cells (antiviral context popularized during COVID). Real biochemistry; clinical evidence in healthy adults is thin.
• Selenium: complementary immune-supporting trace mineral; commonly co-deficient.

Neutral / well-tolerated

• Creatine, omega-3, NAC, ashwagandha, l-theanine, caffeine, modafinil — no meaningful zinc interaction.
• Ashwagandha + zinc is a common male-health stack; safe co-administration (the community-data block confirms this).

Avoid stacking with (or space by ≥2 hours)

• High-dose iron supplements — competitive absorption. Space ≥4 hours.
• Calcium supplements >500 mg — same issue.
• Phytate-heavy meals if your zinc is fasted-only timed. Practical compromise: take zinc with the evening meal, regardless of phytate, because the consistency benefit outweighs the absorption hit.

• Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, moxifloxacin): major interaction. Zinc chelates the quinolone in the gut, reducing antibiotic AUC by 23–85%. Risk: treatment failure. Separate by ≥2 hours before or 6 hours after the antibiotic.
• Tetracyclines (doxycycline, minocycline, tetracycline): same chelation mechanism. Separate by ≥2 hours before or 4 hours after.
• Penicillamine (Wilson's disease, RA): zinc and penicillamine are both copper chelators; combined use depletes copper rapidly.
• Bisphosphonates (alendronate, risedronate): divalent cation chelation — reduces absorption of the bisphosphonate. Space by 2+ hours.
• Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole): chronic PPI use reduces gastric acid → reduced zinc solubility → cumulative zinc depletion. Clinically significant after 6–12 months. Patients on long-term PPIs should monitor zinc.
• Levothyroxine / liothyronine: zinc chelates these in the gut. Separate by ≥4 hours. Also note zinc is a deiodinase cofactor (T4→T3) — so zinc adequacy is supportive of thyroid function while zinc-with-pill timing must be careful.
• ACE inhibitors / ARBs / thiazide diuretics: chronic use increases urinary zinc excretion. Modest depletion; supplement consideration if on long-term therapy.
• Hormonal contraceptives: mild bidirectional effects; not clinically meaningful at standard doses.
• Amphetamine / stimulant ADHD meds: zinc adequacy supports dopaminergic function, and low baseline zinc correlates with reduced stimulant response (relevant for stimulant-prescribed users in family/partner context).
• Alcohol: chronic heavy alcohol use depletes zinc via increased urinary excretion + reduced absorption. Not relevant for the user (zero-alcohol baseline).
• Penicilamine, EDTA, dimercaprol (chelators): all reduce zinc; meaningful only in chelation-therapy contexts.

Zinc is less PGx-driven than psychoactive compounds, but a few variants matter:

• SLC30A8 (ZnT8 transporter): primary insulin-granule zinc transporter in pancreatic β-cells. Common variants (rs13266634, R325W) modestly affect type-2-diabetes risk and possibly zinc handling at the cellular level. Functional implication for healthy users is small.
• SLC39A8 (ZIP8 transporter): rs13107325 (A391T) variant linked to multiple disease phenotypes (Crohn's, schizophrenia, hypertension, lower serum manganese). Real but uncommon.
• MT1/MT2 metallothionein polymorphisms: affect tissue zinc binding capacity and copper handling. Rs28366003 (MT2A) associated with cardiometabolic risk markers in some studies. Clinically actionable insights are limited.
• CA6 (gustin): zinc-dependent salivary carbonic anhydrase; PAV/AVI variants modulate taste sensitivity (bitter perception especially). Niche.
• HFE (hemochromatosis) variants: iron overload genotypes (C282Y, H63D) — relevant because iron-zinc absorption competition can produce relative zinc inadequacy in iron-loaded individuals. Actionable if 23andMe shows HFE risk.
• For the user: Pull 23andMe raw data through Promethease in June 2026; spot-check SLC30A8, SLC39A8, MT2A, HFE. None of these are dose-changing on their own, but HFE-positive flag would slightly raise concern about iron-zinc competition and shift to fully separated dosing.

Form ranking (bioavailability, human RBC/plasma-uptake data):

1. Zinc bisglycinate (glycinate) — best-absorbed in head-to-head trials. Gentle on stomach.
2. Zinc picolinate — Barrie 1987 (PMID 3630857) showed superior hair/urine/RBC uptake vs citrate/gluconate. Good clinical choice.
3. Zinc citrate — solid mid-tier, well-tolerated.
4. Zinc gluconate — standard cheap form; works.
5. Zinc sulfate — older form; works, less gut-friendly.
6. Zinc oxide — poor solubility, near-useless orally (fine topically).

• Acetate is preferred for lozenges (per Hemilä); not commonly available for daily caps.

For the user: Thorne Zinc Bisglycinate 30 mg ($15/2 months) + Thorne Copper Bisglycinate 2 mg ($15/6 months) = ~$3/month all-in. NSF-Certified-for-Sport reduces any future contamination/testing concern even though MMA at amateur level isn't WADA-tested.

Note on hair tissue mineral analysis (HTMA): widely marketed, not reliable for zinc status. External hair contamination, varying growth rate, inconsistent lab methodology. Don't use it.